Guiding Stars: I’m Done Losing Weight on a GLP-1—Now What?
Using GLP-1 agonist medications can improve health outcomes for a growing number of conditions including cardiovascular disease, type 2 diabetes, liver disease, and kidney disease. However, it’s no secret that lots of people take them primarily for weight loss.

AI & Technology

CNH and TIM Invest Around R$ 77 Million To Bring Connectivity to Rural Regions in Brazil

CNH, a global leader in agricultural and construction equipment and technology, and TIM, the leading company in agribusiness connectivity with 100% 4G coverage nationwide, will invest approximately R$77 million in the deployment of 97 new telecommunications towers

Idealist to Celebrate 30 Years of Impact in 2026
For thirty years, Idealist has served the social-impact sector in myriad ways. In 2026, the anniversary of idealist.org’s launch, the nonprofit will feature thirty stories of impact and invite community members to share their own stories.
Subscribe to